BioHemp International, Inc. Aktie Other OTC
Aktien
A2N8AM
US09076B1052
BKIT
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15.05.19 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15.05.19 |
% 1. Jan. | Kap. | |
---|---|---|
+32.09% | 693 Mrd. | |
+29.39% | 584 Mrd. | |
-1.34% | 372 Mrd. | |
+20.34% | 332 Mrd. | |
+7.39% | 294 Mrd. | |
+13.72% | 239 Mrd. | |
-3.03% | 211 Mrd. | |
+10.02% | 210 Mrd. | |
+8.49% | 168 Mrd. |